COVID-19 vaccine candidates: Prediction and validation of 174 novel SARS-CoV-2 epitopes

The recent outbreak of SARS-CoV-2 (2019-nCoV) virus has highlighted the need for fast and efficacious vaccine development. Stimulation of a proper immune response that leads to protection is highly dependent on presentation of epitopes to circulating T-cells via the HLA complex. SARS-CoV-2 is a large RNA virus and testing of all overlapping peptides in vitro to deconvolute an immune response is not feasible. Therefore HLA-binding prediction tools are often used to narrow down the number of peptides to test. We tested 15 epitope-HLA-binding prediction tools, and using an in vitro peptide MHC stability assay, we assessed 777 peptides that were predicted to be good binders across 11 MHC allotypes. In this investigation of potential SARS-CoV-2 epitopes we found that current prediction tools vary in performance when assessing binding stability, and they are highly dependent on the MHC allotype in question. Designing a COVID-19 vaccine where only a few epitope targets are included is therefore a very challenging task. Here, we present 174 SARS-CoV-2 epitopes with high prediction binding scores, validated to bind stably to 11 HLA allotypes. Our findings may contribute to the design of an efficacious vaccine against COVID-19.

[1]  Clemencia Pinilla,et al.  Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior , 2009, BMC Bioinformatics.

[2]  Maria Elena Bottazzi,et al.  The SARS-CoV-2 Vaccine Pipeline: an Overview , 2020, Current Tropical Medicine Reports.

[3]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[4]  Morten Nielsen,et al.  Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions , 2014, BMC Bioinformatics.

[5]  S. Oliver,et al.  Estimating the total number of phosphoproteins and phosphorylation sites in eukaryotic proteomes , 2017, GigaScience.

[6]  Russ B. Altman,et al.  Potential T-cell and B-cell Epitopes of 2019-nCoV , 2020, bioRxiv.

[7]  Luca Antiga,et al.  Automatic differentiation in PyTorch , 2017 .

[8]  H. Rammensee,et al.  Chemistry of peptides associated with MHC class I and class II molecules. , 1995, Current opinion in immunology.

[9]  Morten Nielsen,et al.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method , 2007, BMC Bioinformatics.

[10]  O. Lund,et al.  novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .

[11]  John Sidney,et al.  A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach , 2008, PLoS Comput. Biol..

[12]  M. Nielsen,et al.  NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.

[13]  M. Mann,et al.  Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry , 2016, Nature Communications.

[14]  Collin Tokheim,et al.  Evaluation of machine learning methods to predict peptide binding to MHC Class I proteins , 2017, bioRxiv.

[15]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[16]  Alessandro Sette,et al.  Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method , 2005, BMC Bioinformatics.

[17]  Mujahed I. Mustafa,et al.  Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach , 2020, bioRxiv.

[18]  Jiangning Song,et al.  A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction , 2020, Briefings Bioinform..

[19]  J. Greenbaum,et al.  Improved methods for predicting peptide binding affinity to MHC class II molecules , 2018, Immunology.

[20]  S L Lauemøller,et al.  Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction. , 2002, Tissue antigens.

[21]  Morten Nielsen,et al.  T Cell Epitope Predictions. , 2020, Annual review of immunology.

[22]  N. Hacohen,et al.  A large peptidome dataset improves HLA class I epitope prediction across most of the human population , 2019, Nature Biotechnology.

[23]  Jian Wang,et al.  PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity , 2017, GigaScience.

[24]  Dongsup Kim,et al.  Deep convolutional neural networks for pan-specific peptide-MHC class I binding prediction , 2017, BMC Bioinformatics.

[25]  X. Gu,et al.  DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity , 2019, Front. Immunol..

[26]  S. Brunak,et al.  SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation , 2004, Tissue antigens.

[27]  Morten Nielsen,et al.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.

[28]  M. Nielsen,et al.  NetMHCstab – predicting stability of peptide–MHC‐I complexes; impacts for cytotoxic T lymphocyte epitope discovery , 2014, Immunology.

[29]  R. Scheuermann,et al.  A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.

[30]  Søren Buus,et al.  Functional recombinant MHC class II molecules and high-throughput peptide-binding assays , 2009, Immunome research.

[31]  Morten Nielsen,et al.  The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding , 2009, Bioinform..

[32]  S. Buus,et al.  High‐resolution structure of HLA‐A*1101 in complex with SARS nucleocapsid peptide , 2005, Acta crystallographica. Section D, Biological crystallography.

[33]  U. Şahin,et al.  Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.

[34]  M. Nielsen,et al.  Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays , 2009, Journal of biomolecular screening.

[35]  Kenji Satou,et al.  EpicCapo: epitope prediction using combined information of amino acid pairwise contact potentials and HLA-peptide contact site information , 2012, BMC Bioinformatics.

[36]  Alex Rubinsteyn,et al.  MHCflurry: Open-Source Class I MHC Binding Affinity Prediction. , 2018, Cell systems.

[37]  David Gfeller,et al.  Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity , 2017, bioRxiv.

[38]  Bjoern Peters,et al.  Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens1 , 2009, The Journal of Immunology.

[39]  Nianzhi Zhang,et al.  Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding. , 2019 .